A securities class action lawsuit is pending against Trip.com Group Limited (TCOM) following revelations that the company failed to adequately disclose regulatory risks associated with its automated AI price adjustment tool, which was used to manipulate hotel rates on its platform. On January 14, 2026, China’s State Administration for Market Regulation (SAMR) launched an antitrust investigation into the company, and TCOM stock plummeted 17% that day—with further declines following—as investors learned that the AI tool at the center of the company’s “long-term strategy” was under regulatory scrutiny for allegedly enabling monopolistic conduct. Multiple law firms, including Hagens Berman, Kessler Topaz Meltzer & Check, and Kahn Swick & Foti, are now representing investors who purchased TCOM stock between April 30, 2024 and January 13, 2026, seeking recovery for losses tied to Trip.com’s alleged disclosure failures.
The lawsuit centers on Trip.com’s use of an AI-powered tool that automatically adjusted hotel prices downward whenever the platform detected higher rates from competitors. While Trip.com publicly promoted this tool as central to its business strategy in investor communications, the company allegedly failed to disclose the serious antitrust risks it posed—particularly after Chinese regulators had already begun investigating the practice. When the regulatory probe became public in January 2026, investors faced immediate and substantial losses.
Table of Contents
- What Is the Trip.com AI Price Adjustment Controversy and Antitrust Investigation?
- How Did the AI Tool Enable Monopolistic Conduct Against Hotel Merchants?
- What Was the Stock Price Impact on TCOM Investors?
- What Are the Details of the Pending Securities Class Action Lawsuit?
- What Do the Regulatory Allegations Mean for TCOM Shareholders?
- Timeline of Events: From Regulatory Warning to Public Investigation
- Looking Forward: Regulatory Action, Settlement Prospects, and Investor Recovery
What Is the Trip.com AI Price Adjustment Controversy and Antitrust Investigation?
trip.com’s AI price adjustment tool operated by automatically lowering hotel rates when the platform detected higher prices being charged by competitors—a practice that gave Trip.com a systematic advantage in undercutting rivals and controlling pricing dynamics across its platform. The tool represented more than just a technical feature; Trip.com highlighted it as “a cornerstone of our long-term strategy” in official investor communications, signaling to shareholders that this automated system was vital to the company’s competitive position and revenue model. However, Chinese regulators viewed the tool very differently.
The investigation traces back further than the January 2026 public announcement. In September 2025, regulators from the Zhengzhou market regulator had already summoned Trip.com to address violations of rules against “unfair restrictions” on merchants’ transactions and prices. Despite this warning, Trip.com did not adequately disclose the regulatory risk to investors. The formal antitrust probe by China’s SAMR on January 14, 2026 escalated the situation dramatically, signaling that regulators believed the AI tool’s price manipulation practices constituted a threat to fair competition in China’s travel market.
How Did the AI Tool Enable Monopolistic Conduct Against Hotel Merchants?
The AI price adjustment mechanism gave Trip.com extraordinary control over the pricing environment on its platform. Hotel partners lost meaningful pricing autonomy; rather than setting and maintaining their own rates independently, they faced an algorithmic system that would undercut their prices automatically. More troubling, the tool allegedly enabled Trip.com to force merchant participation in promotions, penalize non-compliant hotels by reducing their visibility, and maintain its own competitive advantage through systematic undercutting. In practical terms, a hotel that tried to maintain standard pricing on its own website might suddenly find itself dramatically undercut on Trip.com without any meaningful control over that outcome.
However, the regulatory concern goes deeper than simple price competition. antitrust laws protect against practices that use dominant market position to unfairly restrict competitors and control merchant behavior—and a large platform automatically adjusting prices on behalf of merchants crosses that line. The distinction matters legally: a platform can compete on price, but it cannot unilaterally manipulate merchant pricing to entrench its own dominance. China’s antitrust regulators flagged exactly this concern, viewing the tool as an unfair restriction on merchants’ ability to set their own prices freely.
What Was the Stock Price Impact on TCOM Investors?
The market reaction to the January 14, 2026 antitrust announcement was swift and severe. TCOM shares fell 17% on that single day as investors absorbed the news that the company’s signature AI strategy was under regulatory investigation. That initial decline was not the end of investor losses; follow-up reporting about the full scope of the investigation and the implications for Trip.com’s business model triggered an additional 19% stock decline in the days following. Combined, shareholders who held TCOM stock during this period experienced a roughly 36% cumulative decline in value, far exceeding normal market volatility.
The timing of the disclosure failures compounds investor losses. Trip.com had been publicly touting the AI price adjustment tool to investors as a cornerstone strategic advantage throughout the class period (April 30, 2024 onward), but did not disclose—or disclose adequately—that regulators had already initiated an investigation into the tool’s legality. Investors who relied on Trip.com’s positive characterization of the tool and the company’s competitive position made investment decisions without material information about regulatory risk. When that risk became public, the stock price reflected reality rather than the incomplete picture Trip.com had presented.
What Are the Details of the Pending Securities Class Action Lawsuit?
The securities class action lawsuit covers TCOM shareholders who purchased stock between April 30, 2024 and January 13, 2026—a period during which Trip.com promoted the AI tool while regulatory risk remained undisclosed. The lawsuit alleges that Trip.com made false or misleading statements regarding the company’s business practices and competitive position, and failed to disclose known regulatory risks associated with the AI price adjustment tool. The company’s omission of information about the September 2025 Zhengzhou market regulator summons is central to the allegation of material non-disclosure.
Four major law firms are currently representing investors in related class action claims: Hagens Berman, Kessler Topaz Meltzer & Check, Kahn Swick & Foti, and Lewis Kahn Esq. The lead plaintiff deadline—the final date by which investors can file to be the named representative plaintiff in the action—is May 11, 2026. Investors who believe they suffered losses due to the stock price decline and Trip.com’s alleged disclosure failures should contact one of these firms to understand their eligibility and options.
What Do the Regulatory Allegations Mean for TCOM Shareholders?
The regulatory allegations against Trip.com carry significant liability implications for shareholders. If Chinese antitrust authorities determine that the AI price adjustment tool constituted monopolistic conduct—using Trip.com’s dominant position to unfairly restrict merchant pricing and competition—the company could face substantial fines, mandatory operational changes, or both. Such regulatory action would directly impact Trip.com’s ability to operate as it has, potentially eliminating a tool the company identified as central to its strategy.
This creates a scenario where investors lost value not only from immediate stock price declines but also from the prospect of long-term operational restrictions. Additionally, the disclosure failure itself poses legal risk to Trip.com. Securities fraud settlements typically require companies to pay damages to shareholders who were harmed by incomplete or misleading statements. Trip.com’s decision not to adequately disclose regulatory investigation until forced to do so by the public announcement means the company may face both regulatory penalties from antitrust authorities and civil liability from shareholders—a dual penalty structure that compounds shareholder harm.
Timeline of Events: From Regulatory Warning to Public Investigation
Understanding the timeline is critical because it reveals the scope of Trip.com’s disclosure failures. In September 2025, the Zhengzhou market regulator summoned Trip.com regarding violations related to unfair pricing restrictions. This was not a minor administrative inquiry—it was a clear regulatory warning that the AI tool’s practices were under scrutiny.
Yet investors heard nothing about this warning; Trip.com continued to promote the tool without adequate disclosure of the regulatory risk. Four months later, on January 14, 2026, SAMR’s formal antitrust probe became public, triggering the massive stock decline and prompting the securities lawsuits. Trip.com responded by shutting down the AI price adjustment tool on March 10, 2026—more than five months after the initial regulatory warning and nearly two months after the public investigation announcement. The extended timeline between the regulatory warning and the tool’s shutdown, combined with Trip.com’s continued public promotion of the tool during that period, strengthens the case for investor claims that material information was withheld.
Looking Forward: Regulatory Action, Settlement Prospects, and Investor Recovery
As of late March 2026, the antitrust investigation remains ongoing, with no final determination yet announced by Chinese regulators. The shutdown of the AI tool suggests Trip.com is attempting to remediate the conduct regulators flagged, which could influence the eventual regulatory outcome and penalties. However, the immediate threat to investor recovery is not the antitrust outcome itself—it is securing class action certification and a fair settlement with Trip.com before the statute of limitations expires.
The securities lawsuit path offers investors a more direct recovery mechanism than waiting for antitrust fines to potentially be distributed. Class action settlements in securities fraud cases typically recover a percentage of shareholder losses directly, rather than recovering only through regulatory fines that benefit the public rather than harmed investors. The May 11, 2026 lead plaintiff deadline is a critical milestone; investors should act now to ensure they are included in the class and positioned to recover losses.